Skip to main content

ESSA Pharma Inc.

EPIXDelisted Oct 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001633932

ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding ESSA Pharma Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of EPIX: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders7080+10
Shares30.8M34.2M+3.32M (+10.8%)
Value$895.7M$976.0M+$80.3M (+9.0%)

New holders (18)

Institutions that held ESSA Pharma Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to EPIX in Q2 2021
InstitutionSharesValue% of portfolio
Artisan Partners Limited Partnership291,091$8.32M0.01%
Darwin Global Management, Ltd.208,524$5.96M0.96%
Vanguard Group Inc75,498$2.16M0.00%
BlackRock Inc.66,387$1.90M0.00%
Swiss National Bank47,100$1.35M0.00%
Bank of Montreal42,500$1.34M0.00%
Price T Rowe Associates Inc24,303$694.0K0.00%
HighVista Strategies LLC24,026$686.0K0.49%
AlpInvest Partners B.V.21,646$618.0K0.30%
Alliancebernstein L.P.15,745$450.0K0.00%
Marshall Wace, LLP14,479$414.0K0.00%
Credit Suisse AG12,226$348.0K0.00%
Virtus ETF Advisers LLC8,233$235.0K0.10%
Deutsche Bank AG1,563$45.0K0.00%
Legal & General Group Plc924$26.0K0.00%
BNP Paribas Arbitrage, SA431$12.3K0.00%
Harbour Investments, Inc.300$9.00K0.00%
US Bancorp17$00.00%

Sold out (8)

Institutions that held ESSA Pharma Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of EPIX in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Ikarian Capital, LLC264,868$7.69M
Silverarc Capital Management, LLC73,451$2.13M
Pinz Capital Management, LP38,578$1.12M
Boothbay Fund Management, LLC31,599$918.0K
Jane Street Group, LLC29,449$855.0K
Atom Investors LP27,122$788.0K
HRT Financial LP24,616$715.0K
Athanor Capital, LP7,758$225.0K